On January 13, 2015, Neptune and NeuroBioPharm, a subsidiary of Neptune, announced that they entered into an arrangement agreement which will result in the indirect acquisition by Neptune of all of the issued and outstanding shares of NeuroBioPharm. For more information on the arrangement agreement, please see documentation below.